AAAAAA

   
Results: 1-7 |
Results: 7
Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma
Authors: Nemunaitis, J Fong, T Shabe, P Martineau, D Ando, D
Citation: J. Nemunaitis et al., Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma, CANCER INV, 19(3), 2001, pp. 239-247
A prescription for gene therapy
Authors: Aguilar, LK Aguilar-Cordova, E Ando, D Armendariz-Borunda, J Burd, PR Butler, EB Carter, B Chiang, YL Glorioso, JC Henderson, DR Jolly, D McKenny, GP Nemunaitis, J Rives, M Scherer, S Woo, SLC
Citation: Lk. Aguilar et al., A prescription for gene therapy, MOL THER, 1(5), 2000, pp. 385-388
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients
Authors: Fujii, S Huang, S Fong, TC Ando, D Burrows, F Jolly, DJ Nemunaitis, J Hoon, DSB
Citation: S. Fujii et al., Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients, CANC GENE T, 7(9), 2000, pp. 1220-1230
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells
Authors: Tani, K Nakazaki, Y Hase, H Takahashi, K Azuma, M Ohata, J Kitamura, R Komine, F Oiwa, M Masunaga, A Maekawa, T Satoh, N Adachi, D Soda, Y Machida, U Endo, M Yamazaki, T Watari, K Tojo, A Yamashita, N Tomikawa, S Eriguchi, M Hamada, H Wakumoto, Y Hanazawa, K Okumura, K Fujime, M Shuin, T Kawai, K Akaza, H Clift, S Ando, D Sherwin, S Mulligan, R Asano, S
Citation: K. Tani et al., Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells, CANC CHEMOT, 46, 2000, pp. S73-S76
Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma
Authors: Nemunaitis, J Fong, T Burrows, F Bruce, J Peters, G Ognoskie, N Meyer, W Wynne, D Kerr, R Pippen, J Oldham, F Ando, D
Citation: J. Nemunaitis et al., Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma, HUM GENE TH, 10(8), 1999, pp. 1289-1298
Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma
Authors: Nemunaitis, J Fong, T Robbins, JM Edelman, G Edwards, W Paulson, RS Bruce, J Ognoskie, N Wynne, D Pike, M Kowal, K Merritt, J Ando, D
Citation: J. Nemunaitis et al., Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma, CANC GENE T, 6(4), 1999, pp. 322-330
Design and performance of the Elefant Digitizer IC for the BaBar drift chamber
Authors: Dow, SF Karcher, A Levi, ME Momayezi, M von der Lippe, H Ando, D
Citation: Sf. Dow et al., Design and performance of the Elefant Digitizer IC for the BaBar drift chamber, IEEE NUCL S, 46(4), 1999, pp. 785-791
Risultati: 1-7 |